Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

130 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
Serum soluble mediators as prognostic biomarkers for morbidity, disease outcome, and late-relapsing hepatitis in yellow fever patients.
Fradico JRB, Campi-Azevedo AC, Speziali E, do Valle Antonelli LR, Peruhype-Magalhães V, de Rezende IM, Alves PA, Pascoal-Xavier MA, Pereira LS, Dutra MRT, Ramalho DB, Cenachi A, de Paula L, Santos TA, do Carmo Said RF, Calzavara-Silva CE, Coelho-Dos-Reis JGA, de Magalhães CR, Rabelo LLC, Valim V, Brito-de-Sousa JP, da Costa-Rocha IA, de Souza Gomes M, Amaral LR, de Lima SMB, Trindade GF, Santos RT, da Silva JFA, Monath T, LaBeaud AD, Drumond BP, Martins-Filho OA, Teixeira-Carvalho A; Yellow Fever Collaborative Group. Fradico JRB, et al. Among authors: labeaud ad. Clin Immunol. 2023 Jun;251:109321. doi: 10.1016/j.clim.2023.109321. Epub 2023 Apr 3. Clin Immunol. 2023. PMID: 37019421
Characterization and Investigation of Risk Factors for Late-Relapsing Hepatitis After Yellow Fever.
Rezende IM, McClure MA, Pereira LS, Fradico JRB, Cenachi ARC, Moura AS, Paladino LLA, Dutra MRT, Alves PA, Xavier MAP, Said RFDC, Ramalho DB, Gama TDP, Martins-Filho OA, Monath TP, Teixeira-Carvalho A, Drumond BP, LaBeaud AD; Yellow Fever Collaborative Group. Rezende IM, et al. Among authors: labeaud ad. Clin Infect Dis. 2023 Aug 22;77(4):565-573. doi: 10.1093/cid/ciad249. Clin Infect Dis. 2023. PMID: 37099356 Free PMC article.
Wild-type Yellow fever virus in cerebrospinal fluid from fatal cases in Brazil, 2018.
de Rezende IM, Cenachi ARC, Costa TA, Oliveira GFG, Rabelo L, Menezes LM, Penido I, Pereira LS, Arruda MS, Gonç Alves AP, Alves PA, Kroon EG, Calzavara-Silva CE, Ramalho DB, Martins-Filho OA, Teixeira-Carvalho A, LaBeaud AD, Drumond BP. de Rezende IM, et al. Among authors: labeaud ad. Front Virol. 2022;2:936191. doi: 10.3389/fviro.2022.936191. Epub 2022 Sep 9. Front Virol. 2022. PMID: 37461745 Free PMC article.
Yellow Jack's Potential Return to the American South.
Hotez PJ, LaBeaud AD. Hotez PJ, et al. Among authors: labeaud ad. N Engl J Med. 2023 Oct 19;389(16):1445-1447. doi: 10.1056/NEJMp2308420. Epub 2023 Oct 14. N Engl J Med. 2023. PMID: 37843124 No abstract available.
Antibiotic prescribing patterns at outpatient clinics in Western and Coastal Kenya.
Kiener M, Ichura C, Ndenga BA, Mutuku FM, Winter CA, Okuta V, Mwambingu L, Ogamba K, Shaita KN, Ronga C, Chebii P, Amugongo J, Malumbo S, Godana O, Jembe Z, Ng'ang'a C, Mazera M, LaBeaud AD. Kiener M, et al. Among authors: labeaud ad. PLOS Glob Public Health. 2025 Jan 3;5(1):e0004109. doi: 10.1371/journal.pgph.0004109. eCollection 2025. PLOS Glob Public Health. 2025. PMID: 39752345
Understanding the factors contributing to dengue virus and chikungunya virus seropositivity and seroconversion among children in Kenya.
Tariq A, Khan A, Mutuku F, Ndenga B, Bisanzio D, Grossi-Soyster EN, Jembe Z, Maina P, Chebii P, Ronga C, Okuta V, LaBeaud AD. Tariq A, et al. Among authors: labeaud ad. PLoS Negl Trop Dis. 2024 Nov 20;18(11):e0012616. doi: 10.1371/journal.pntd.0012616. eCollection 2024 Nov. PLoS Negl Trop Dis. 2024. PMID: 39565798 Free PMC article.
Molecular epidemiology and evolutionary characteristics of dengue virus 2 in East Africa.
Nyathi S, Rezende IM, Walter KS, Thongsripong P, Mutuku F, Ndenga B, Mbakaya JO, Aswani P, Musunzaji PS, Chebii PK, Maina PW, Mutuku PS, Ng'ang'a CM, Malumbo SL, Jembe Z, Vu DM, Mordecai EA, Bennett S, Andrews JR, LaBeaud AD. Nyathi S, et al. Among authors: labeaud ad. Nat Commun. 2024 Sep 7;15(1):7832. doi: 10.1038/s41467-024-51018-0. Nat Commun. 2024. PMID: 39244569 Free PMC article.
Sofosbuvir Off-label Treatment of Yellow Fever Patients During an Outbreak in Brazil, 2018: A Cohort Study.
Rezende IM, Mendonça DC, Costa TA, de Oliveria GFG, Arruda MS, Gonçalves AP, Alves PA, Calzavara-Silva CE, Martins-Filho OA, Teixeira-Carvalho A, Bonjardim CA, Monath TP, LaBeaud AD, Drumond BP, Pascoal-Xavier MA, Pereira LS, Ramalho DB. Rezende IM, et al. Among authors: labeaud ad. Open Forum Infect Dis. 2024 Jun 6;11(6):ofae312. doi: 10.1093/ofid/ofae312. eCollection 2024 Jun. Open Forum Infect Dis. 2024. PMID: 38933737 Free PMC article.
130 results